RBP4: A Potential Drug Target and Biomarker (G5950)

Target Name: RBP4

NCBI ID: G5950

RBP4

RBP4: A Potential Drug Target and Biomarker

Ribosomal binding protein 4 (RBP4) is a protein that plays a critical role in the regulation of gene expression in eukaryotic cells. It is a 28-kDa protein that is expressed in various cell types and is composed of two heavy chains and two light chains.RP4 is highly conserved across different species, and it has been implicated in various cellular processes, including cell growth, apoptosis, and translation of mRNAs.

RP4 has been identified as a potential drug target in the pharmaceutical industry due to its unique structure and its involvement in various cellular processes. Several studies have shown that inhibiting RP4 can lead to therapeutic effects, such as inhibiting the growth of cancer cells and treating neurodegenerative diseases.

RP4 is also being investigated as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The expression of RP4 has been shown to be elevated in various diseases, including cancer, and it is potential target for drugs that can inhibit its activity.

RP4 is a protein that is expressed in various cell types, including muscle, heart, brain, and cancer cells. It is also expressed in various organs, including the liver, and it is involved in the regulation of cellular processes, including cell growth, apoptosis, and translation of mRNAs. RP4 is composed of two heavy chains and two light chains, and it has a molecular weight of 28 kDa.

RP4 is highly conserved across different species, and it has been implicated in various cellular processes, including cell growth, apoptosis, and translation of mRNAs. It is a protein that plays a critical role in regulating the expression of various genes in eukaryotic cells.

RP4 has been identified as a potential drug target in the pharmaceutical industry due to its unique structure and its involvement in various cellular processes. Several studies have shown that inhibiting RP4 can lead to therapeutic effects, such as inhibiting the growth of cancer cells and treating neurodegenerative diseases.

In addition to its potential therapeutic uses, RP4 has also been investigated as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The expression of RP4 has been shown to be elevated in various diseases, including cancer, and it is potential target for drugs that can inhibit its activity.

RP4 is a protein that is expressed in various cell types, including muscle, heart, brain, and cancer cells. It is also expressed in various organs, including the liver, and it is involved in the regulation of cellular processes, including cell growth, apoptosis, and translation of mRNAs. RP4 is composed of two heavy chains and two light chains, and it has a molecular weight of 28 kDa.

RP4 is highly conserved across different species, and it has been implicated in various cellular processes, including cell growth, apoptosis, and translation of mRNAs. It is a protein that plays a critical role in regulating the expression of various genes in eukaryotic cells.

RP4 has been identified as a potential drug target in the pharmaceutical industry due to its unique structure and its involvement in various cellular processes. Several studies have shown that inhibiting RP4 can lead to therapeutic effects, such as inhibiting the growth of cancer cells and treating neurodegenerative diseases.

In addition to its potential therapeutic uses, RP4 has also been investigated as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The expression of RP4 has been shown to be elevated in various diseases, including cancer, and it is potential target for drugs that can inhibit its activity.

Protein Name: Retinol Binding Protein 4

Functions: Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496)

The "RBP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets